Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
St. John's Wort Extract LI 160 in Atypical Depression
NCT00861978Phase 3Completed
- Sponsor
- Cassella-med
- Start
- Dec 2002
- Primary completion
- Nov 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in atypical depression comparing Placebo with St. John's Wort extract (2 arms). Primary endpoint: Relative change of the Hamilton Depression Rating Scale (17-item) from Baseline at 8 weeks. Started Dec 2002; status: completed.
02
Drugs
hypericum perforatum
03
Conditions
atypical depression
Beyond the preview
Go deeper on NCT00861978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00861978.